What is the Future of Biomarker Development in Cancer?
The future of cancer biomarker development lies in the integration of artificial intelligence and machine learning to analyze large datasets, uncover new biomarkers, and predict treatment responses. Additionally, advances in next-generation sequencing and multi-omics approaches are expected to lead to the discovery of novel biomarkers. These innovations will likely enhance the precision and personalization of cancer care, paving the way for more effective and tailored treatment strategies.
